年龄、肌酐和射血分数评分对STEMI患者经皮冠状动脉介入术后1年预后的预测价值

杨昕宇, 顾怡钰, 徐明珠, 等. 年龄、肌酐和射血分数评分对STEMI患者经皮冠状动脉介入术后1年预后的预测价值[J]. 临床心血管病杂志, 2020, 36(8): 719-723. doi: 10.13201/j.issn.1001-1439.2020.08.009
引用本文: 杨昕宇, 顾怡钰, 徐明珠, 等. 年龄、肌酐和射血分数评分对STEMI患者经皮冠状动脉介入术后1年预后的预测价值[J]. 临床心血管病杂志, 2020, 36(8): 719-723. doi: 10.13201/j.issn.1001-1439.2020.08.009
YANG Xinyu, GU Yiyu, XU Mingzhu, et al. Value of ACEF score in evaluating one-year prognosis after percutaneous coronary intervention in STEMI patients[J]. J Clin Cardiol, 2020, 36(8): 719-723. doi: 10.13201/j.issn.1001-1439.2020.08.009
Citation: YANG Xinyu, GU Yiyu, XU Mingzhu, et al. Value of ACEF score in evaluating one-year prognosis after percutaneous coronary intervention in STEMI patients[J]. J Clin Cardiol, 2020, 36(8): 719-723. doi: 10.13201/j.issn.1001-1439.2020.08.009

年龄、肌酐和射血分数评分对STEMI患者经皮冠状动脉介入术后1年预后的预测价值

  • 基金项目:

    苏州大学附属第一医院心血管专业组临床试验能力提升项目(No:201900180019)

    江苏干部保健科研课题(No:BJ15010)

详细信息
    通讯作者: 蒋廷波,E-mail:18906201122@189.cn
  • 中图分类号: R542.2

Value of ACEF score in evaluating one-year prognosis after percutaneous coronary intervention in STEMI patients

More Information
  • 目的:评价接受直接经皮冠状动脉介入手术(PCI)的ST段抬高型心肌梗死(STEMI)患者的年龄、肌酐和射血分数(ACEF)评分对于患者术后1年预后的预测价值。方法:回顾性纳入2014年6月-2018年6月于苏州大学附属第一医院行PCI术的STEMI患者754例,根据患者1年内是否出现主要不良心血管事件(MACE)分为病例组185例及对照组569例。收集患者的临床资料,计算ACEF评分,根据三分位数将患者分成低危组(ACEF评分≤1.09,258例)、中危组(1.09<ACEF评分≤1.46,248例)和高危组(ACEF评分>1.46,248例),比较3组患者1年内MACE的发生情况。结果:ACEF评分是STEMI患者1年内MACE发生的独立危险因素,与其他指标相比,其预测价值更高(AUC=0.784,95%CI:0.748~0.820,P=0.000)。高危组患者平均年龄更大,发生心房颤动、心力衰竭、室性心动过速以及心室颤动的比例更高(均P<0.05)。ACEF评分越高,术后1年内发生MACE的风险越高(log-rank P=0.000),发生时间越早。结论:ACEF评分对STEMI患者PCI术后1年预后有着良好的预测价值。
  • 加载中
  • [1]

    Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Rev Esp Cardiol (Engl Ed),2017,70(12):1082.

    [2]

    Roffi M,Patrono C,Collet JP,et al.2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J].Kardiol Pol.2015,73(12):1207-1294.

    [3]

    Ranucci M,Castelvecchio S,Conte M,et al.The easier,the better:age,creatinine,ejection fraction score for operative mortality risk stratification in a series of 29,659 patients undergoing elective cardiac surgery[J].J Thorac Cardiovasc Surg,2011,142(3):581-586.

    [4]

    Barili F,Pacini D,Grossi C,et al.Reliability of new scores in predicting perioperative mortality after mitral valve surgery[J].J Thorac Cardiovasc Surg,2014,147(3):1008-1012.

    [5]

    Stahli BE,Wischnewsky MB,Jakob P,et al.Predictive value of the age,creatinine,and ejection fraction (ACEF) score in patients with acute coronary syndromes[J].Int J Cardiol,2018,270:7-13.

    [6]

    Synetos A,Georgiopoulos G,Pylarinou V,et al.Comparison of prognostic risk scores after successful primary percutaneous coronary intervention[J].Int J Cardiol,2017,230:482-487.

    [7]

    Levine GN,Bates ER,Blankenship JC,et al.2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction[J].J Am Coll Cardiol,2016,67(10):1235-1250.

    [8]

    Deng J,Wang X,Shi Y,et al.Prognostic value of the age,creatinine,and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients:A retrospective study[J].J Interv Cardiol,2018,31(1):33-40.

    [9]

    尉驰,闫浩东,徐力红,等.ACEF评分对急性冠状动脉综合征患者经皮冠状动脉介入治疗术后6个月内再次血运重建的评估价值[J].中国心血管杂志,2019,24(6):501-506.

    [10]

    Knott KD,Seraphim A,Augusto JB,et al.The prognostic significance of quantitative myocardial perfusion:An artificial intelligence based approach using perfusion mapping[J].Circulation,2020,141(16):1282-1291.

    [11]

    Janella BL,Campos CM,Caixeta A,et al.Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention:comparison of multiple anatomical and clinical prognostic risk scores[J].EuroIntervention,2017,13(10):1177-1184.

    [12]

    Reindl M,Reinstadler SJ,Tiller C,et al.ACEF score adapted to ST-elevation myocardial infarction patients:The ACEF-STEMI score[J].Int J Cardiol,2018,264:18-24.

    [13]

    高国峰,周林丽,张冬,等.ACEF评分在中国经皮冠状动脉介入治疗患者中的预测价值研究[J].中国循环杂志,2019,34(11):1047-1054.

    [14]

    Lee JH,Bae MH,Yang DH,et al.Prognostic value of the age,creatinine,and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction[J].Am J Cardiol,2015,115(9):1167-1173.

    [15]

    Sbrocchi AJ,Denlinger CE.Occam's razor:What is the best approach for a lobectomy?[J].J Thorac Cardiovasc Surg,2018,156(1):363-364.

    [16]

    Gao S,Liu Q,Ding X,et al.Predictive value of the combination of age,creatinine,and ejection fraction score and diabetes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention[J].Coron Artery Dis,2020,31(2):109-117.

    [17]

    Gao G,Zhang D,Song C,et al.Integrating the residual SYNTAX score to improve the predictive ability of the age,creatinine,and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients[J].Catheter Cardiovasc Interv,2020,95 Suppl 1:534-541.

  • 加载中
计量
  • 文章访问数:  118
  • PDF下载数:  57
  • 施引文献:  0
出版历程
收稿日期:  2020-03-16
修回日期:  2020-05-15

目录